Date:15/07/2005 URL: http://www.thehindubusinessline.com/2005/07/15/stories/2005071501880200.htm

Back Ranbaxy gets tentative USFDA nod for HIV drug

Our Bureau

New Delhi , July 14

RANBAXY Laboratories Ltd has received tentative approval from the US Food and Drug Administration (FDA) to manufacture and market zidovudine tablets 300 mg used in combination with other anti-retroviral (ARV) agents in the treatment of HIV infection.

This is the first approval granted by the US regulator for generic zidovudine and Ranbaxy's third tentative approval under the US President's Emergency Plan for AIDS relief.